(Q30830669)

26 June 2017

1 reference

title

Epidemiology of drug-resistant malaria (English)

1 reference

26 June 2017

0 references

1 reference

4

Steven R Meshnick

1 reference

PubMed ID

11937421

26 June 2017

Walther H Wernsdorfer

series ordinal

3

object named as

Walther H Wernsdorfer

1 reference

26 June 2017

Chansuda Wongsrichanalai

series ordinal

1

1 reference

PubMed ID

11937421

26 June 2017

Amy L Pickard

series ordinal

2

1 reference

26 June 2017

1 April 2002

1 reference

26 June 2017

10

1 reference

Lancet Infectious Diseases

inferred from page(s)

published in

1 reference

26 June 2017

2

1 reference

26 June 2017

209-218

1 reference

26 June 2017

4

1 reference

The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden

26 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

The dynamics of drug resistance in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

The epidemiology of drug-resistant malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Chloroquine-resistant malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Antimalarial drug resistance and combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Modern chemotherapeutic options for malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Transmission control and drug resistance in malaria: a crucial interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Epidemiology of drug resistance in malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Modelling a predictable disaster: the rise and spread of drug-resistantmalaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Quinine sensitivity of isolates of Plasmodium falciparum from the coast of Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildren.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Chemoresistance of P. falciparum in urban areas of Yaounde, Cameroon. Part 1: Surveillance of in vitro and in vivo resistance of Plasmodium falciparum to chloroquine from 1994 to 1999 in Yaounde, Cameroon

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

A molecular marker for chloroquine-resistant falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Analysis of the key pfcrt point mutation and in vitro and in vivo response to chloroquine in Yaoundé, Cameroon

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Prevalence of the K76T mutation in the putative Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene and its relation to chloroquine resistance in Mozambique

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Plasmodium falciparum malaria in Laos: chloroquine treatment outcome and predictive value of molecular markers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Sequence polymorphisms in pfcrt are strongly associated with chloroquine resistance in Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Analysis of the PfCRT K76T mutation in Plasmodium falciparum isolates from the Amazon region of Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Polymorphism of the Pfmdr1 gene and chloroquine resistance in Plasmodium falciparum in The Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Correlation of in vivo-resistance to chloroquine and allelic polymorphisms in Plasmodium falciparum isolates from Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: evidence for quinine resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Pfmdr1 Asn1042Asp and Asp1246Tyr polymorphisms, thought to be associated with chloroquine resistance, are present in chloroquine-resistant and -sensitive Brazilian field isolates of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Mutations in the pfmdr1, dhfr and dhps genes of Plasmodium falciparum are associated with in-vivo drug resistance in West Papua, Indonesia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Molecular epidemiology of Plasmodium falciparum antifolate resistance in Vietnam: genotyping for resistance variants of dihydropteroate synthase and dihydrofolate reductase.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Molecular analysis of DHFR and DHPS genes in P. falciparum clinical isolates from the Haut--Ogooué region in Gabon

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Point mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum isolates from Venezuela.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the Amazon Region of Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Plasmodium falciparum: linkage disequilibrium between loci in chromosomes 7 and 5 and chloroquine selective pressure in Northern Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Malaria reemergence in the Peruvian Amazon region

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Sulfadoxine-pyrimethamine for the treatment of Plasmodium falciparum malaria in Gabonese children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Chloroquine- and sulfadoxine-pyrimethamine-resistant Falciparum malaria in vivo - a pilot study in rural Zambia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

In vitro susceptibility of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine, and sulfadoxine/pyrimethamine in Equatorial Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Follow-up of the susceptibility of Plasmodium falciparum to antimalarials in Gabon.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Patterns of Plasmodium falciparum drug resistance in nonimmune travellers to Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

In vitro susceptibility of Plasmodium falciparum isolates from Myanmar to antimalarial drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Mefloquine resistant malaria in Cameroon and correlation with resistance to quinine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Antimalarial drug combination policy: a caveat

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900239-6

7 January 2021

10.1016/S1473-3099(02)00239-6

Identifiers

DOI

1 reference

26 June 2017

1 reference

PubMed ID

11937421